Volume 29, Number 10—October 2023
Dispatch
Outbreak of Sexually Transmitted Nongroupable Neisseria meningitidis–Associated Urethritis, Vietnam
Hao Trong Nguyen1, Thanh V. Phan1, Hau Phuc Tran, Thao Thi Phuong Vu, Nhi Thi Uyen Pham, Tho Thi Thanh Nguyen, Ha Manh Bui, Bao Hac Duong, Thu Nguyen Anh Luu, Nguyen Nhat Pham, Phuc Duy Nguyen, Tu Ngoc Le, Thu Quang Le, Dai Thi Trang Vo, Lan Trong Phan, Nghia Van Khuu, Quang Duy Pham, and Thuong Vu Nguyen
Table 2
Correlates of demographic characteristics, STI symptoms and pathogens among male patients with N. meningitidis US NmNG urethritis and controls, Vietnam*
| Variables | Cases, n = 19 | Controls, n = 76 | Univariable analysis† |
Multivariable analysis† |
|||
|---|---|---|---|---|---|---|---|
| OR (95% CI) | p value | aOR (95% CI) | p value | ||||
| Mean age, y | 26.9 | 27.8 | 0.90 (0.75–1.07) | 0.232 | NA | ||
| Mean years of education | 10.8 | 11.0 | 0.96 (0.75–1.23) | 0.760 | NA | ||
| Medical examination >3 d after symptom onset |
13 (68.4) |
11 (14.5) |
18.41 (4.04–83.86) |
<0.001 |
16.00 (2.00–127.54) |
0.009 |
|
| Symptoms | |||||||
| Pyuria | 2 (10.5) | 10 (13.2) | 0.79 (0.16–3.79) | 0.764 | NA | ||
| Dysuria | 13 (68.4) | 65 (85.5) | 0.39 (0.12–1.19) | 0.098 | NA | ||
| Burning sensation during urination | 2 (10.5) | 57 (75.0) | 0.05 (0.01–0.22) | <0.001 | 0.08 (0.01–0.46) | 0.005 | |
| Discharge |
4 (21.1) |
16 (21.1) |
1.00 (0.26–3.89) |
>0.999 |
|||
| Time between symptom onset and medical consultation, d | |||||||
| Mean | 4.7 | 3.0 | 1.92 (1.18–3.13) | 0.009 | NA | ||
| Median (range) |
5 (3–12) |
3 (1–14) |
|||||
| History of meningococcal vaccine | |||||||
| Ever | 0 | 1 (1.3) | NA | ||||
| Never | 12 (63.2) | 51 (67.1) | NA | ||||
| Do not know, do not remember |
7 (36.8) |
24 (31.6) |
NA |
||||
| Positive tests | |||||||
| HIV | 2 (10.5) | 6 (7.9) | 1.36 (0.26–7.20) | 0.716 | NA | ||
| Syphilis | 2 (10.5) | 3 (3.9) | 2.67 (0.45–15.96) | 0.283 | NA | ||
| Gonorrhea | 0 (0.0) | 75 (98.7) | NA | NA | |||
| Chlamydia | 4 (21.1) | 7 (9.2) | 2.57 (0.67–9.83) | 0.168 | 3.83 (0.37–39.43) | 0.258 | |
| Ureaplasma | 1 (5.3) | 8 (10.5) | 0.48 (0.06–4.01) | 0.502 | NA | ||
| Mycoplasma | 1 (5.3) | 10 (13.2) | 0.39 (0.04–3.10) | 0.372 | NA | ||
*Values are no. (%) except as indicated. aOR, adjusted odds ratio; NA, not applicable; OR, odds ratio. †Conditional logistic regression.
1These first authors contributed equally to this article.
Page created: August 14, 2023
Page updated: September 21, 2023
Page reviewed: September 21, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.